ZAVICEFTA® has proven bactericidal activity against a broad spectrum of resistant Gram-negative pathogens1–3
ZAVICEFTA® has in vitro activity against MDR P. aeruginosa, CRE, including KPC- and OXA-48-producing strains, and ESBL- and AmpC-producing bacteria1-3,6-8
Avibactam inhibits majority of β-lactamases2,9-12